Canaccord Genuity raises Exact Sciences stock price target to $85 on strong growth
PositiveFinancial Markets

Canaccord Genuity has raised its price target for Exact Sciences to $85, reflecting strong growth prospects for the company. This adjustment highlights investor confidence in Exact Sciences' ability to expand and succeed in the competitive healthcare market, making it a noteworthy development for stakeholders and potential investors.
— Curated by the World Pulse Now AI Editorial System








